Disease-modifying therapies for multiple sclerosis
- PMID: 30482751
- DOI: 10.1136/bmj.k4674
Disease-modifying therapies for multiple sclerosis
Conflict of interest statement
Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following interests: WJB has received speaker fees for educational activities from Merck Serono, which produces interferon beta-1a used to treat multiple sclerosis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical